mRNA Vaccine Market Report

China mRNA Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：175
  • REPORT CODE：GMM1836245
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the mRNA Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • eTheRNA

    • BioNTech

    • In-Cell-Art

    • Sangamo Therapeutics

    • Argos Therapeutics

    • Ethris

    • Tiba Biotechnology

    • Moderna Therapeutics

    • Translate Bio

    By Type:

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Standardization Of Cancer Treatment MRNA Vaccine

    By Application:

    • Infectious Disease

    • Cancer

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China mRNA Vaccine Market Overview 2018-2029

    • 1.1 China mRNA Vaccine Industry Development Overview

    • 1.2 China mRNA Vaccine Industry Development History

    • 1.3 China mRNA Vaccine Industry Market Size (2018-2029)

    • 1.4 China mRNA Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China mRNA Vaccine Production Volume, Production Value and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2029)

      • 1.4.2 China mRNA Vaccine Production Volume, Production Value and Growth Rate of Infection Prevention MRNA Vaccine (2018-2029)

      • 1.4.3 China mRNA Vaccine Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2029)

      • 1.4.4 China mRNA Vaccine Production Volume, Production Value and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine (2018-2029)

    • 1.5 China mRNA Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)

      • 1.5.2 China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.3 China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China mRNA Vaccine Market Analysis by Region

      • 1.6.1 North China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China mRNA Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China mRNA Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on mRNA Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China mRNA Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China mRNA Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China mRNA Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on mRNA Vaccine Industry Development

    Chapter 3 mRNA VaccineIndustry Chain Analysis

    • 3.1 mRNA Vaccine Industry Chain

    • 3.2 mRNA Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the mRNA Vaccine Market

    • 3.3 mRNA Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the mRNA Vaccine Market

    Chapter 4 China mRNA Vaccine Market, by Type

    • 4.1 China mRNA Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China mRNA Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China mRNA Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China mRNA Vaccine Production Volume and Growth Rate of Infectious Disease Treatment MRNA Vaccine

      • 4.5.2 China mRNA Vaccine Production Volume and Growth Rate of Infection Prevention MRNA Vaccine

      • 4.5.3 China mRNA Vaccine Production Volume and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

      • 4.5.4 China mRNA Vaccine Production Volume and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

    Chapter 5 China mRNA Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China mRNA Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China mRNA Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China mRNA Vaccine Market Size and Growth Rate of Infectious Disease

      • 5.5.2 China mRNA Vaccine Market Size and Growth Rate of Cancer

      • 5.5.3 China mRNA Vaccine Market Size and Growth Rate of Other

    Chapter 6 China mRNA Vaccine Market, by Region

    • 6.1 China mRNA Vaccine Production Volume and Production Value, by Region

    • 6.2 China mRNA Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China mRNA Vaccine Market Analysis

    • 7.1 North China mRNA Vaccine Market, by Type

    • 7.2 North China mRNA Vaccine Market, by Application

    Chapter 8 Central China mRNA Vaccine Market Analysis

    • 8.1 Central China mRNA Vaccine Market, by Type

    • 8.2 Central China mRNA Vaccine Market, by Application

    Chapter 9 South China mRNA Vaccine Market Analysis

    • 9.1 South China mRNA Vaccine Market, by Type

    • 9.2 South China mRNA Vaccine Market, by Application

    Chapter 10 East China mRNA Vaccine Market Analysis

    • 10.1 East China mRNA Vaccine Market, by Type

    • 10.2 East China mRNA Vaccine Market, by Application

    Chapter 11 Northeast China mRNA Vaccine Market Analysis

    • 11.1 Northeast China mRNA Vaccine Market, by Type

    • 11.2 Northeast China mRNA Vaccine Market, by Application

    Chapter 12 Southwest China mRNA Vaccine Market Analysis

    • 12.1 Southwest China mRNA Vaccine Market, by Type

    • 12.2 Southwest China mRNA Vaccine Market, by Application

    Chapter 13 Northwest China mRNA Vaccine Market Analysis

    • 13.1 Northwest China mRNA Vaccine Market, by Type

    • 13.2 Northwest China mRNA Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 eTheRNA

        • 14.1.1 eTheRNA Company Profile

        • 14.1.2 eTheRNA mRNA Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BioNTech

        • 14.2.1 BioNTech Company Profile

        • 14.2.2 BioNTech mRNA Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 In-Cell-Art

        • 14.3.1 In-Cell-Art Company Profile

        • 14.3.2 In-Cell-Art mRNA Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sangamo Therapeutics

        • 14.4.1 Sangamo Therapeutics Company Profile

        • 14.4.2 Sangamo Therapeutics mRNA Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Argos Therapeutics

        • 14.5.1 Argos Therapeutics Company Profile

        • 14.5.2 Argos Therapeutics mRNA Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ethris

        • 14.6.1 Ethris Company Profile

        • 14.6.2 Ethris mRNA Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Tiba Biotechnology

        • 14.7.1 Tiba Biotechnology Company Profile

        • 14.7.2 Tiba Biotechnology mRNA Vaccine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Moderna Therapeutics

        • 14.8.1 Moderna Therapeutics Company Profile

        • 14.8.2 Moderna Therapeutics mRNA Vaccine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Translate Bio

        • 14.9.1 Translate Bio Company Profile

        • 14.9.2 Translate Bio mRNA Vaccine Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 mRNA Vaccine Industry Research Conclusions

    • 15.2 mRNA Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China mRNA Vaccine Industry Market Size (2018-2029)

    • Figure China mRNA Vaccine Production Volume, Production Value and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccine Production Volume, Production Value and Growth Rate of Infection Prevention MRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccine Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccine Production Volume, Production Value and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)

    • Figure China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China mRNA Vaccine Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China mRNA Vaccine Market Size and Growth Rate from 2018-2029

    • Figure mRNA Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China mRNA Vaccine Market Share by Type in 2018

    • Figure China mRNA Vaccine Market Share by Type in 2023

    • Figure China mRNA Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China mRNA Vaccine Production Volume and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccine Production Volume and Growth Rate of Infection Prevention MRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccine Production Volume and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccine Production Volume and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccine Market Share by Application in 2018

    • Figure China mRNA Vaccine Market Share by Application in 2023

    • Figure China mRNA Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China mRNA Vaccine Market Size and Growth Rate of Infectious Disease (2018-2023)

    • Figure China mRNA Vaccine Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China mRNA Vaccine Market Size and Growth Rate of Other (2018-2023)

    • Table China mRNA Vaccine Production Volume by Region (2018-2023)

    • Table China mRNA Vaccine Production Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccine Production Volume Share by Region (2018-2023)

    • Table China mRNA Vaccine Production Value by Region (2018-2023)

    • Table China mRNA Vaccine Production Value Share by Region (2018-2023)

    • Figure China mRNA Vaccine Production Value Share by Region (2018-2023)

    • Table China mRNA Vaccine Sales Volume by Region (2018-2023)

    • Table China mRNA Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccine Sales Volume Share by Region (2018-2023)

    • Table China mRNA Vaccine Sales Value by Region (2018-2023)

    • Table China mRNA Vaccine Sales Value Share by Region (2018-2023)

    • Figure China mRNA Vaccine Sales Value Share by Region (2018-2023)

    • Table North China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table North China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table North China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table North China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table Central China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table Central China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table South China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table South China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table South China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table East China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table East China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table East China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China mRNA Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China mRNA Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China mRNA Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China mRNA Vaccine Sales Volume Share by Application (2018-2023)

    • Table eTheRNA Company Profile

    • Table eTheRNA mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table BioNTech Company Profile

    • Table BioNTech mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table In-Cell-Art Company Profile

    • Table In-Cell-Art mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Sangamo Therapeutics Company Profile

    • Table Sangamo Therapeutics mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Argos Therapeutics Company Profile

    • Table Argos Therapeutics mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Ethris Company Profile

    • Table Ethris mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Tiba Biotechnology Company Profile

    • Table Tiba Biotechnology mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Moderna Therapeutics Company Profile

    • Table Moderna Therapeutics mRNA Vaccine Revenue, Price and Gross (2018-2023)

    • Table Translate Bio Company Profile

    • Table Translate Bio mRNA Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US